Raghu Ganugula

1.3k total citations
46 papers, 1.1k citations indexed

About

Raghu Ganugula is a scholar working on Molecular Biology, Clinical Biochemistry and Biomaterials. According to data from OpenAlex, Raghu Ganugula has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Clinical Biochemistry and 7 papers in Biomaterials. Recurrent topics in Raghu Ganugula's work include Advanced Glycation End Products research (9 papers), Natural Antidiabetic Agents Studies (7 papers) and Pomegranate: compositions and health benefits (6 papers). Raghu Ganugula is often cited by papers focused on Advanced Glycation End Products research (9 papers), Natural Antidiabetic Agents Studies (7 papers) and Pomegranate: compositions and health benefits (6 papers). Raghu Ganugula collaborates with scholars based in United States, India and United Kingdom. Raghu Ganugula's co-authors include G. Bhanuprakash Reddy, M. N. V. Ravi Kumar, Meenakshi Arora, Palla Suryanarayana, Anil Kumar Pasupulati, V Reddy, Puppala Muthenna, Prabhjot K. Saini, Nagalla Balakrishna and Madhoosudan A. Patil and has published in prestigious journals such as Journal of the American Chemical Society, ACS Nano and PLoS ONE.

In The Last Decade

Raghu Ganugula

44 papers receiving 1.1k citations

Peers

Raghu Ganugula
Raghu Ganugula
Citations per year, relative to Raghu Ganugula Raghu Ganugula (= 1×) peers Narayanasamy Angayarkanni

Countries citing papers authored by Raghu Ganugula

Since Specialization
Citations

This map shows the geographic impact of Raghu Ganugula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghu Ganugula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghu Ganugula more than expected).

Fields of papers citing papers by Raghu Ganugula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghu Ganugula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghu Ganugula. The network helps show where Raghu Ganugula may publish in the future.

Co-authorship network of co-authors of Raghu Ganugula

This figure shows the co-authorship network connecting the top 25 collaborators of Raghu Ganugula. A scholar is included among the top collaborators of Raghu Ganugula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghu Ganugula. Raghu Ganugula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ganugula, Raghu, et al.. (2025). Dual-function polyester nanoparticles for amplified anti-inflammatory effects. Science Advances. 11(32). eadw1358–eadw1358. 2 indexed citations
3.
Harwood, Janet, et al.. (2025). Urolithin A-laden functional nanoparticles alleviate cisplatin-induced cardiotoxicity in mice by inhibiting inflammation-induced lymphangiogenesis. Free Radical Biology and Medicine. 237. 491–502. 1 indexed citations
4.
Ganugula, Raghu, et al.. (2024). Engineered urolithin A-laden functional polymer-lipid hybrid nanoparticles prevent cisplatin-induced proximal tubular injury in vitro. European Journal of Pharmaceutics and Biopharmaceutics. 200. 114334–114334. 6 indexed citations
5.
Arora, Meenakshi, et al.. (2024). Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies. Pharmacological Reviews. 77(1). 100003–100003. 4 indexed citations
6.
Arora, Meenakshi, et al.. (2024). Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS Nano. 18(18). 11863–11875. 4 indexed citations
7.
Arora, Meenakshi, et al.. (2023). Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological Reviews. 76(2). 228–250. 1 indexed citations
8.
Ganugula, Raghu, et al.. (2023). Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin. ACS Applied Materials & Interfaces. 15(39). 45651–45657. 9 indexed citations
9.
Ganugula, Raghu, Meenakshi Arora, Subhash Dwivedi, et al.. (2023). Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease. ACS Nano. 17(7). 6857–6874. 35 indexed citations
10.
Uppada, Srijayaprakash, Erin M. Scott, Gladys Y.‐P. Ko, et al.. (2022). Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an Ex Vivo Rat Eye Model. ACS Chemical Neuroscience. 13(14). 2092–2098. 1 indexed citations
11.
Ganugula, Raghu, Meenakshi Arora, Bani K. Mallick, et al.. (2020). Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Science Advances. 6(35). eabb7878–eabb7878. 24 indexed citations
12.
Ganugula, Raghu, et al.. (2020). A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Science Advances. 6(24). eabb3900–eabb3900. 35 indexed citations
13.
Kaur, Ginpreet, Meenakshi Arora, Raghu Ganugula, & M. N. V. Ravi Kumar. (2019). Double-headed nanosystems for oral drug delivery. Chemical Communications. 55(33). 4761–4764. 9 indexed citations
14.
Ganugula, Raghu, Meichun Deng, Meenakshi Arora, Hui‐Lin Pan, & M. N. V. Ravi Kumar. (2019). Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy. ACS Chemical Neuroscience. 10(3). 1801–1812. 11 indexed citations
15.
16.
Ganugula, Raghu, Meenakshi Arora, & M. N. V. Ravi Kumar. (2017). Ex Vivo Rat Eye Model for Investigating Transport of Next Generation Precision-Polyester Nanosystems. ACS Applied Materials & Interfaces. 9(31). 25668–25671. 3 indexed citations
17.
Ganugula, Raghu, et al.. (2017). Next Generation Precision-Polyesters Enabling Optimization of Ligand–Receptor Stoichiometry for Modular Drug Delivery. Journal of the American Chemical Society. 139(21). 7203–7216. 26 indexed citations
18.
Ganugula, Raghu, et al.. (2017). Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform. ACS Macro Letters. 6(2). 161–164. 18 indexed citations
19.
Ganugula, Raghu, Meenakshi Arora, Ruedeekorn Wiwattanapatapee, et al.. (2017). Nano‐curcumin safely prevents streptozotocin‐induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus. British Journal of Pharmacology. 174(13). 2074–2084. 89 indexed citations
20.
Reddy, G. Bhanuprakash, et al.. (2013). Antiglycating potential of procyanidin-B2 isolated from cinnamon bark: Prevention or treatment of diabetic ocular complications (cataract & retinopathy). Investigative Ophthalmology & Visual Science. 54(15). 1945–1945. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026